miR-19 Is a Potential Clinical Biomarker for Gastrointestinal Malignancy: A Systematic Review and Meta-analysis

Figure 3

Forest plot of odds ratio (OR). (a) Comparison of the expression level of miR-19 between liver cancer and control. (b) Comparison of the expression level of miR-19 between colorectal cancer and control. (c) Comparison of the expression level of miR-19 between gastric cancer and control. (d) Comparison of the expression level of miR-19 between pancreatic cancer and control.

(a)

(b)

(c)

(d)